Introduction
============

Retrograde, or centripetal, flow was originally identified as the net transport of surface receptors and the underlying actin cytoskeleton from the cell cortex toward the center of the cell ([@bib9]; [@bib74]). This process has been studied extensively in motile cells, including neuronal growth cones, cultured fibroblasts, and fish keratocytes ([@bib25]; [@bib17]; [@bib67]), where it is required for the generation of traction forces on the substratum for cell movement and necessary for the maintenance of polarized, directional growth. Retrograde actin flow also occurs in nonmotile cells, such as sea urchin coelomocytes ([@bib26]). In both motile and nonmotile cells, retrograde flow occurs as a result of two forces; the "push" of actin polymerization caused by the addition of G-actin at the barbed ends of elongating actin filaments at the cell cortex, and the "pull" of myosin molecules further back in the network. Numerous studies, including those using inhibitors for myosin or myosin light chain kinase, have implicated conventional type II myosin in retrograde actin flow ([@bib39]; [@bib22]; [@bib10]; [@bib34]; [@bib48]). Other studies have also implicated tropomyosin in the regulation of actin flow, through the isoform-specific regulation of both the length of the actin network and the rate of retrograde flow ([@bib23]).

Retrograde actin flow similar to that observed in cortical actin networks in motile and nonmotile cells also occurs in polarized actin bundles within microvilli, filopodia, and stereocilia (for review see [@bib40]). In each of these cortical protrusions, actin bundles elongate by the addition of new material to the tip of the bundle, which comprises F-actin barbed ends and a "tip complex" detected by ultrastructural analysis ([@bib46]; [@bib60]; [@bib70]). Imaging of actin dynamics revealed that addition of material to the tip of actin bundles results in retrograde, or centripetal, flow of F-actin within the bundle from the tip toward the base of the bundle ([@bib56]).

Several lines of evidence indicate that actin cables in budding yeast are conserved structures, which exhibit retrograde flow. Actin cables are parallel bundles of F-actin that align along the mother-bud axis and contain cross-linking and stabilizing proteins, including fimbrin (Sac6p), Abp140p, and two tropomyosin isoforms (Tpm1p and Tpm2p; [@bib1]; [@bib13]; [@bib42]; [@bib12]; [@bib27]; [@bib2]; [@bib3]; [@bib52]; [@bib65]). Actin cables are required for the localization of vacuoles, secretory vesicles, mitochondria, late-Golgi components, spindle alignment elements, and *ASH1* mRNA to the developing bud ([@bib42]; [@bib36]; [@bib28]; [@bib64]; [@bib66]; [@bib52]; [@bib55]; [@bib61]). With the exception of mitochondria, which use Arp2/3 complex--mediated actin polymerization for anterograde movement ([@bib7]), all of the other particles that rely on actin cables for distribution require type V myosin for localization in the bud. In the case of secretory vesicles and spindle-alignment elements, bud- directed movement is linear and occurs at a velocity that is directly proportional to the length of the type V myosin lever arm ([@bib61]; [@bib30]). Thus, there is evidence that actin cables serve as tracks for myosin-driven, bud-directed particle movement. Moreover, because type V myosins are barbed-end--directed motors, it is likely that actin cables, like actin bundles in other eukaryotes, consist of actin filaments that are physically or functionally polarized with their barbed end oriented toward their assembly site in the bud.

Recent studies indicate that actin cables undergo retrograde flow. Previously, we showed that actin cables are labeled in living cells using an Abp140p-GFP fusion protein ([@bib75]). Time-lapse imaging of Abp140p-GFP revealed that actin cables are dynamic structures that assemble in the bud and bud neck and exhibit assembly-dependent retrograde flow away from assembly sites along the mother-bud axis. Fluorescence loss in photobleaching experiments and analysis of the movement of fiduciary marks of Abp140p-GFP on motile actin cables revealed that insertion of material at the tip of the cable located within the bud results in retrograde movement of the entire cable toward the mother cell. Consistent with these findings, other laboratories showed that the yeast formins Bni1p and Bnr1p are required for actin cable stability, have the capacity to stimulate actin polymerization, and localize to the sites of actin cable assembly detected using Abp140p-GFP ([@bib35]; [@bib32]; [@bib15]; [@bib51]; [@bib57],[@bib58]; [@bib11]).

Our previous results also showed that actin cable movement could be mediated by assembly-independent mechanisms. Specifically, we found that fixed-length fragments of actin cables, which are produced by treatment with low levels of the actin monomer--sequestering factor latrunculin A, move along the cell cortex. This movement did not depend on actin cable assembly and occurred parallel to the long axis of the actin cable ([@bib75]). These findings raised the possibility that myosin molecules that are anchored to the cortex could provide a pulling force for actin cable retrograde flow. *Saccharomyces cerevisiae* has five myosin genes: two type I myosin genes (*MYO3* and *MYO5*), one type II myosin gene (*MYO1*), and two type V myosin genes (*MYO2* and *MYO4*; [@bib73]; [@bib33]; [@bib24]; [@bib19]; [@bib20]). Type I myosins localize to actin patches (actin-coated endosomes), where they contribute to the control of actin organization, endocytosis, and activation of the actin nucleation activity of the Arp2/3 complex ([@bib20]; [@bib14]; [@bib37]; [@bib31]; [@bib21]). The type II myosin of yeast localizes to the bud neck, and has been implicated in cytokinesis ([@bib5]; [@bib41]; [@bib71]). Finally, type V myosins are motors for bud-directed cargo movement along actin cables, and accumulate in the bud tip ([@bib38]; [@bib61]; [@bib30]). We studied the role of yeast myosins in actin cable dynamics.

In complementary studies, we evaluated the role of yeast tropomyosins in retrograde actin cable flow. The yeast tropomyosins share 64% homology, and show similar affinities for binding to F-actin. Deletion of both Tpm1p and Tpm2p results in cell death in budding yeast. These findings indicate that Tpm1p and Tpm2p together support an essential function in budding yeast. Because both proteins localize to actin cables, and actin cables are essential for cell viability in budding yeast, it is likely that the essential function supported by Tpm1p and Tpm2p is stabilization of actin cables. On the other hand, overexpression of *TPM2* in yeast bearing a deletion in *TPM1* does not suppress the defects in growth or chitin deposition associated with the *tpm1Δ* deletion. Moreover, actin cables are destabilized in *tpm1Δ*, but not in *tpm2Δ* mutants, ([@bib12]). These findings indicate that the two tropomyosin isoforms of budding yeast carry out distinct functions, and that the primary function of Tpm1p is control of actin cable stability, along with its function in chitin deposition and bud growth.

We report novel roles for a type II myosin (Myo1p) and a specific tropomyosin isoform (Tpm2p) in retrograde actin cable flow in budding yeast. Our findings indicate that retrograde actin flow is conserved from yeast to humans, and raise the possibility that budding yeast may be useful as a model system for studying this fundamental process. Our studies also support an isoform-specific function for Tpm1p in promoting actin cable activity as a track for myosin-driven anterograde cargo movement.

Results
=======

Role for type II myosin (Myo1p) in retrograde actin cable flow
--------------------------------------------------------------

In wild-type cells, actin cables extend from the bud tip or bud neck along the mother-bud axis. In yeast bearing deletions in the type I myosins, actin cables do not align along the mother-bud axis and are less robust than those observed in wild-type cells; however, actin cables are present in these cells. To analyze the rate of retrograde actin cable flow, we monitored as a function of time the change in position of either the tips of Abp140p-GFP--labeled actin cables, or of fiduciary marks of Abp140p-GFP on actin cables ([Fig. 1 A](#fig1){ref-type="fig"}). The velocity of retrograde actin cable flow in various myosin mutants and their corresponding wild-type controls are shown ([Table I](#tbl1){ref-type="table"}). Because the velocity of retrograde actin cable flow was similar in all wild-type stains analyzed at 23 and 37°C (0.36--0.38 μm/s), the velocity of actin cable movement in various myosin mutants was compared with the mean velocity of all wild-type strains evaluated ([Fig. 1 B](#fig1){ref-type="fig"}).

![**Type II myosin is necessary for normal rates of actin cable retrograde flow.** Wild-type and mutant strains were grown in selective media at RT to early log phase. For all mutants other than *myo2-66 myo4Δ*, time-lapse imaging was performed at RT. For temperature-sensitive *myo2-66 myo4Δ* mutants, strains were grown at RT and shifted to 37°C for 30 min before imaging. Imaging of Abp140p-GFP--labeled actin cables in a single cortical focal plane was performed as described in Materials and methods. (A) Still-frame images of a time-lapse series of Abp140p-GFP--labeled actin cables in *myo1Δ* (THY120; top) and the corresponding wild-type strain (YCY027; bottom). Arrowheads point to fiduciary marks, or regions of increased actin content in the actin cable, at t = 0 of image analysis. (B) Average rates of retrograde flow of Abp140p-GFP--labeled actin cables in wild-type cells (YCY027), a type I myosin mutant (*myo3Δ* *myo5Δ*; YCY009), and a type II myosin mutant (*myo1Δ*; THY120) at RT, as well as a type V myosin mutant (*myo2-66 myo4Δ*; YCY010) at 37°C. Rates of movement were determined as described in Materials and methods. Error bars represent the SD. *n* \> 20 for each strain. Asterisk indicates statistically different rates, P \< 0.01. Bar, 2 μm.](jcb1750957f01){#fig1}

###### 

**Velocities of retrograde actin cable flow in myosin mutants and the corresponding wild-type strains**

  ------------------------------------------------------------------------------------------------------------------------------------------------------------
  Strain                              Genotype                                                                Retrograde actin cable flow rate   
  ----------------------------------- ----------------------------------------------------------------------- ---------------------------------- -------------
                                                                                                              *μm/s*                             *μm/s*

  S288C wild type for *myo1Δ* and\    MATα *his3Δ* *leu2Δ* *met15Δ* *ura3Δ* *ABP140∷GFP∷KanMX6*               0.38 ± 0.08                        0.38 ± 0.08
       *myo2-66 myo4Δ* (YCY027)                                                                                                                  

  W303 wild type for *myo3Δ myo5Δ*\   MATα *can1-100 ade2-1 his3-11 leu2-3,112 ura3-1 trp1-1*\                0.36 ± 0.1                         nd
      (YCY006)                             *ABP140*∷*GFP*∷*KanMX6*                                                                               

  *myo1Δ* (THY120)                    MATα *leu2-3,112 ura3-52 ade1-101 myo1Δ*∷*URA3     ABP140∷GFP∷KanMX6*   0.19 ± 0.07                        nd

  *myo2-66 myo4Δ* (VSY21)             MATα *leu2-3,112 his3-200 ura3-52 myo2-66*∷HIS3\                        0.40 ± 0.06                        0.38 ± 0.08
                                           *myo4Δ*∷*URA3*                                                                                        

  *myo3Δ* *myo5Δ* (YCY009)            MATα *can1-100 ade2-1 his3-11 leu2-3,112 ura3-1 trp1-1*\                0.29 ± 0.06                        nd
                                           *myo3Δ*∷HIS3 *myo5Δ*∷*TRP1 ABP140*∷*GFP*∷*KanMX6*                                                     
  ------------------------------------------------------------------------------------------------------------------------------------------------------------

nd, no data.

The retrograde flow rate of actin cables in strains bearing a deletion in the two type I myosins of yeast (*myo3Δ* *myo5Δ*) was not significantly different from rates observed in corresponding wild-type cells at 23°C. Because the type V myosin gene *MYO2* is essential, we studied the effect of loss of type V myosin function using a yeast strain bearing a temperature-sensitive mutation in the *MYO2* gene and a deletion in *MYO4,* which is the other, nonessential, type V myosin gene. We found that the rate of retrograde actin cable flow in this strain (*myo2-66 myo4Δ*) was similar to that observed in wild-type cells upon incubation at permissive (23°C) or restrictive (37°C) temperatures. In contrast, in the strain lacking the type II myosin (*myo1Δ*), the rate of retrograde actin cable flow of 0.19 μm/s was significantly lower than that observed in the wild-type control (P \< 0.01). These findings indicate that type II myosin of budding yeast is required for normal rates of retrograde actin cable flow ([Fig. 1](#fig1){ref-type="fig"} and [Table I](#tbl1){ref-type="table"}).

Type II myosin localizes to the bud neck from the time of commitment to a round of cell division (G~1~) to the end of the cell division cycle. We tested whether this localization of type II myosin is critical for retrograde actin cable flow by taking advantage of the finding that overexpression of the tail of type II myosin acts in a dominant-negative fashion and causes delocalization of the endogenous, full-length protein from the bud neck ([@bib69]). We inserted the C-terminal 868 amino acids of the type II myosin into a multicopy plasmid under control of the galactose-inducible *GAL1* promoter. The resulting plasmid, pGal-MYO1-tail, was used to evaluate the effect of regulated overexpression of the type II myosin tail on the localization of endogenous, GFP-tagged type II myosin and on the dynamics of actin cables.

We confirmed that the addition of GFP to the C terminus of the endogenous type II myosin gene (*MYO1*) had no obvious effect on cell viability, polarity, or growth rates (unpublished data). As expected, we found that full-length, GFP-tagged type II myosin (Myo1p-GFP) forms a ring at the bud neck in untransformed cells, as well as in cells that were transformed with pGal-MYO1-tail and incubated under noninducing conditions ([Fig. 2 A](#fig2){ref-type="fig"}). Thus, endogenous type II myosin exhibits normal localization when the pGal-MYO1-tail expression is not induced. In contrast, galactose-induced overexpression of pGal-MYO1-tail caused mislocalization of endogenous, GFP-tagged type II myosin from the bud neck to the cytosol ([Fig. 2 B](#fig2){ref-type="fig"}).

![**Normal localization of type II myosin is necessary for normal rates of actin cable retrograde flow.** Wild-type cells expressing Myo1p-GFP from the genomic locus were transformed with pGal-MYO1-tail (THY159). Cells were grown in the glucose-based media to mid-log phase and shifted to fresh media containing either glucose or galactose for 4 h. Imaging was performed at a single central plane. (A and B) Fluorescence images from a single optical plane illustrating the localization of full-length, GFP-tagged type II myosin protein (Myo1p-GFP) in cells transformed with pGal-MYO1-tail after growth under noninducing conditions (glucose; A) and under inducing conditions (galactose; B). Bar, 1 μm. (C) The rates of retrograde flow of Abp140p-GFP--labeled actin cables were analyzed in wild-type cells (YCY027), *myo1Δ* cells (THY120), and cells bearing wild-type *MYO1* that were transformed with pGal-MYO1-tail (THY160) upon growth in a carbon source that either induces (galactose) or does not induce (glucose) overexpression of the type II myosin tail construct. Analyses of the rates of retrograde flow were determined as in [Fig. 1](#fig1){ref-type="fig"}. In the absence of induction of pGal-MYO1-tail (glucose), normal rates of actin cable retrograde flow were observed. Growth for 4 h under inducing conditions (galactose) causes a significant reduction in the rate of retrograde flow of Abp140p-labeled actin cables, compared with that observed under noninducing conditions (P \< 0.01). Error bars represent the SD. *n* \> 20 for each strain.](jcb1750957f02){#fig2}

Using Abp140p-GFP as a marker for actin cables, we found that wild-type cells bearing pGal-MYO1-tail showed normal rates of actin cable retrograde flow when grown under noninducing conditions. However, galactose-induced overexpression of pGal-MYO1-tail resulted in a significant decrease in the rate of retrograde actin cable flow ([Fig. 2 C](#fig2){ref-type="fig"}). Indeed, the retrograde flow rate in cells expressing the dominant-negative pGal-MYO1-tail construct was similar to that observed upon deletion of *MYO1*. This decrease in the rate of retrograde flow was not the result of incubation in galactose, as wild-type cells grown in galactose showed no change in actin cable retrograde flow rate. Instead, these findings indicate that localization of type II myosin at the bud neck is important for its function in retrograde actin cable flow.

The motor domain of type II myosin is required for its function in retrograde actin cable flow
----------------------------------------------------------------------------------------------

Two approaches were taken in our study of the role of the myosin motor in retrograde actin cable flow. The first approach was based on recent findings that the Myo1p tail supports cytokinesis when expressed in lieu of full-length Myo1p and at a level similar to that of endogenous, wild-type Myo1p ([@bib45]). The Myo1p tail and full-length Myo1p were expressed in *myo1Δ* cells using the plasmids constructed by [@bib45], and retrograde actin cable flow was examined in these cells using Abp140p-GFP. Full-length Myo1p and the Myo1p tail localize to the bud neck, as previously reported ([@bib45]). The velocity of retrograde actin cable flow observed upon expression of full-length, plasmid-borne Myo1p (0.419 μm/s; *n* = 32) was similar to that observed in yeast expressing endogenous, wild-type *MYO1*. In contrast, expression of the Myo1p tail alone resulted in a reduced rate of retrograde actin cable flow (0.227 μm/s; *n* = 33) that was similar to that observed in untransformed *myo1Δ* cells and in *myo1Δ* cells that were transformed with the vector used for Myo1p and Myo1p tail expression. Thus, the motor domain of *MYO1* is required for normal rates of retrograde actin cable flow.

As a second approach to study the role for the type II myosin motor activity in retrograde actin cable flow, we constructed a mutant that carries a single amino acid substitution in the Myo1p motor domain, which inhibits the ATP-sensitive actin-binding activity of the protein. The site was chosen for mutagenesis based on the observation that the corresponding mutation in the essential type V myosin of budding yeast, the *myo2-66* mutation, produces a temperature-dependent loss of cell viability ([@bib33]). The *myo2-66* mutation is a substitution of lysine for glutamic acid 511 ([@bib38]), a residue conserved in all yeast myosin proteins ([Fig. 3 A](#fig3){ref-type="fig"}) that corresponds to Glu527 in chicken skeletal muscle myosin and Glu528 in yeast type II myosin. X-ray crystallography of chicken skeletal muscle myosin mapped this residue to the actin-binding face of the lower 50-kD component of the motor domain, and showed that this glutamic acid forms a salt bridge with Lys486, which is another highly conserved residue in the motor domain ([@bib53]).

![**Construction and expression of the *myo1-66* mutant.** (A) Sequence alignment of the five *S. cerevisiae* myosin genes shows absolute conservation of a glutamate in the ATP-binding pocket of the motor domain. (B) *myo1Δ* cells expressing plasmid-borne, GFP-tagged wild-type (THY194) or *myo1-66* mutant (THY195) type II myosin were grown at RT in selective media to mid-log phase and incubated at either RT or 37°C for 30 min. Optical z-series imaging was performed, and the resulting images were subjected to digital deconvolution. Images shown are 2D projections of 3D stacks and are representative of the larger cell population. Cell outlines are shown in white. GFP-tagged *myo1-66p* localizes to the bud neck, similar to wild-type Myo1p-GFP after incubation at RT or 37°C. Bar, 2 μm. (C) *myo1Δ* cells expressing plasmid-borne, GFP-tagged wild-type (THY194) or *myo1-66* mutant (THY195) type II myosin were grown at RT in selective media to mid-log phase and incubated at either RT or 37°C for 30 min. Whole-cell lysates were evaluated by SDS-PAGE and Western blot analysis using antibodies specific for GFP to detect tagged myosin proteins and hexokinase (Hxk1p) as the loading control. *myo1-66p*-GFP is expressed at a slightly reduced level relative to wild-type Myo1p-GFP. Short-term incubation at 37°C had no obvious effect on the steady-state level of either Myo1p or myo1-66p.](jcb1750957f03){#fig3}

To generate the mutant, the type II myosin gene (*MYO1*), which was tagged with GFP at its C terminus, was inserted into a low-copy (CEN) plasmid under control of the endogenous type II myosin promoter. Glu528 was than replaced with Lys in the plasmid-borne, *MYO1* GFP-tagged gene. We refer to the mutated gene as *myo1-66* to indicate that it shares the same mutation as *myo2-66*. The GFP-tagged *myo1-66* mutant was expressed in lieu of wild-type myosin II, i.e., in a yeast strain bearing a deletion in the *MYO1* gene (p*myo1-66 myo1Δ*). Using Western blots probed with anti-GFP antibody, we found that the steady-state level of myo1-66p was 70% of the wild-type type II myosin level upon growth at permissive temperature (23°C) or after incubation at restrictive temperature (37°C) for 30 min ([Fig. 3 C](#fig3){ref-type="fig"}). Moreover, *myo1-66* cells exhibited elevated levels of multibudded cells; the level of multibudded cells in these cultures increased upon incubation at 37°C (unpublished data). Nonetheless, the *myo1-66* mutant protein localized normally to the bud neck throughout the cell cycle ([Fig. 3 B](#fig3){ref-type="fig"}). Moreover, the growth rate of these *myo1-66* cells at 23°C was similar to that observed for the corresponding wild-type strain at 23°C. Finally, *myo1-66* cells did not show temperature-dependent lethality, as expected, because type II myosin is not essential in the yeast genetic background used for these studies ([Fig. 3](#fig3){ref-type="fig"}).

The effect of the *myo2-66* mutation on the mechanochemical properties of type V myosin of yeast is not known. Therefore, we evaluated the rigor-binding activity of wild-type Myo1p and mutant myo1-66p to actin ([Fig. 4 A](#fig4){ref-type="fig"}). Wild-type myosin was immobilized on magnetic beads and incubated with yeast F-actin in the presence of ATP or ADP. In the presence of ATP, F-actin did not bind to wild-type type II myosin. However, in the presence of ADP, there was a significant increase in the amount of F-actin binding. Thus, we concluded that type II myosin exhibits ATP-sensitive actin-binding activity. Mutant *myo1-66* protein also exhibited ATP-sensitive actin- binding activity under these experimental conditions. However, actin-binding activity of the mutant *myo1-66* protein was lower than that observed in the wild-type protein ([Fig. 4 A](#fig4){ref-type="fig"}). This decrease in actin binding to mutant type II myosin was evident at all concentrations of actin tested ([Fig. 4 B](#fig4){ref-type="fig"}). Because wild-type protein lost activity after short-term incubation at elevated temperatures, we could not test whether the *myo1-66* mutation confers temperature-dependent loss of actin-binding activity in vitro. Nonetheless, our results indicate that substitution of Glu528 with Lys in the actin-binding site of the type II myosin motor domain reduces the ATP-sensitive actin-binding activity of the protein.

![**myo1-66p binds actin less effectively than wild-type Myo1p.** Rigor-binding assays for GFP-tagged wild-type Myo1p and myo1-66p were performed by incubating myosin-bound magnetic beads with various concentrations of actin for 90 s in the presence of 1 mM ATP or ADP at 4°C, as described in Materials and methods. (A) Western blots showing bound and unbound fractions from a representative rigor-binding assay performed using 10 μM actin. Asterisks indicate IgG used to tether myosin to the beads. BSA-coated beads were used as a control for nonspecific actin binding. Magnetic bead fraction (B) and unbound fraction (U) were solubilized in SDS sample buffer. Equal volumes of solubilized samples were subjected to PAGE and Western blot analysis using antibodies specific for GFP and actin. (B) Quantitation by densitometric analysis of Western blots showing the amount of actin bound to immobilized wild-type or mutant type II myosin after incubation with 0.5--2 μM actin.](jcb1750957f04){#fig4}

Given a clear understanding of the effect of the *myo1-66* mutation on the type II myosin motor domain, we examined the retrograde flow rates of Abp140p-GFP--labeled actin cables in the *myo1-66* mutant, relative to the wild-type ([Fig. 5, A and B](#fig5){ref-type="fig"}). At 23°C, the rate of retrograde actin cable flow in yeast expressing the *myo1-66* mutant was similar to that observed in yeast expressing wild-type myosin II protein ([Fig. 5 B](#fig5){ref-type="fig"}). Thus, the mutant protein supports normal rates of retrograde flow at reduced temperatures, despite the fact that it is present at lower levels compared with wild-type cells. The rate of retrograde actin cable flow in wild-type cells was not affected by incubation at 37°C. In contrast, the rate of actin cable retrograde flow is significantly reduced in yeast expressing the *myo1-66* mutant at 37°C. ([Fig. 5, A and B](#fig5){ref-type="fig"}). However, the rate of retrograde actin cable flow observed in the *myo1-66* mutant at restrictive temperatures is similar to that observed in yeast bearing a deletion in *MYO1* and in yeast expressing the Myo1p tail at wild-type levels in lieu of full-length Myo1p ([Fig. 5 B](#fig5){ref-type="fig"}). Thus, the *myo1-66* mutant exhibits temperature- dependent reduction in the rate of retrograde actin cable flow. These data suggest that normal rates of actin cable retrograde flow require a functional type II myosin motor domain.

![**Normal rates of actin cable retrograde flow require the actin-binding activity of type II myosin.** The retrograde flow rate of Abp140p-labeled actin cables was examined in cells expressing wild-type *MYO1* (YCY027) or *myo1-66p* (THY193) as the sole copy of type II myosin. Imaging was performed as described for [Fig. 1](#fig1){ref-type="fig"}. (A) Average rates of retrograde flow of Abp140p-GFP--labeled actin cables in wild-type cells, *myo1-66* mutant at RT and 37°C, and *myo1Δ* cells that express full-length Myo1p (TLY002) or the Myo1p tail (TLY003) from low-copy, centromere-based plasmids (pTL2 and pTL3) under control of the *MYO1* promoter. Rates of movement were determined as described in Materials and methods. At 37°C, there is a significant reduction in the rate of actin cable retrograde flow in *myo1-66* cells compared with corresponding wild-type cells (P \< 0.05). The rate of retrograde actin cable flow in the *myo1-66* cell at restrictive temperatures is similar to that of the *myo1Δ* cell expressing Myo1p tail. Error bars represent the SD. *n* \> 20 for each strain. (B) Still-frame images of a time-lapse series of Abp140p-GFP--labeled actin cables in the *myo1-66* mutant at 23 (top) and 37°C (bottom). Arrowheads point to an Abp140p-GFP fiduciary mark on an actin cable undergoing retrograde flow. Arrows point to the position of the fiduciary mark at t = 0 of image analysis. Bar, 2 μm.](jcb1750957f05){#fig5}

Isoform-specific role for Tpm2p in retrograde actin cable flow in vivo
----------------------------------------------------------------------

Earlier studies suggested that deletion of *TPM1* results in loss of actin cables ([@bib12]). However, with the advent of more sensitive optical imaging technology, it is now clear that deletion of *TPM1* reduces the length and/or abundance of actin cables, but does not result in the complete loss of these structures. Time-lapse videos illustrating retrograde flow of actin cables in wild-type cells and *tpm1Δ* mutants are shown (Videos 1 and 2, available at <http://www.jcb.org/cgi/content/full/jcb.200609155/DC1>). Because actin cables are present in both *tpm1Δ* and *tpm2Δ* cells, we studied the effect of loss of the yeast tropomyosins on actin cable dynamics. We found that the rate of actin cable retrograde flow in *tpm1Δ* strains was not significantly different from that observed in wild-type cells ([Fig. 6](#fig6){ref-type="fig"}). In the *tpm2Δ* strain, however, the rate of actin cable retrograde flow was 0.78 μm/s, which is approximately twice that observed in wild-type cells ([Fig. 6, A and B](#fig6){ref-type="fig"}). This finding indicates that actin cable retrograde flow can occur at rates that are at least twice the mean rate of flow observed in wild-type cells. Equally important, this finding indicates that Tpm2p, but not Tpm1p, reduces the rate of retrograde actin cable flow.

![**Loss of Tpm2p causes a significant increase in actin cable retrograde flow rate.** The retrograde flow rate of Abp140p-labeled actin cables was examined in wild-type cells (YCY027) and in cells carrying a deletion of *TPM1* (THY118), *TPM2* (THY119), or *MDM20* (THY114-2d). Imaging and analysis of retrograde actin flow rates were performed as described for [Fig. 1](#fig1){ref-type="fig"}. (A) Average rates of retrograde flow of Abp140p-GFP--labeled actin cables in wild-type cells, and *mdm20Δ*, *tpm1Δ*,or *tpm2Δ* mutants, at RT. Rates of movement were determined as described in Materials and methods. Deletion of *TPM2* caused a significant increase in the rate of actin cable retrograde flow (P \< 0.01), as indicated by the asterisk. Error bars represent the SD. *n* \> 20 for each strain. (B) Still-frame images of a time-lapse series of Abp140p-GFP--labeled actin cables in wild-type cells (top) and the *tpm2Δ* mutant (bottom) at 23°C. Arrowheads point to an Abp140p-GFP fiduciary mark on an actin cable undergoing retrograde flow. Arrows point to the position of the fiduciary mark at t = 0 of image analysis. Bar, 2 μm.](jcb1750957f06){#fig6}

To further explore the role of Tpm1p in retrograde actin cable flow, we studied Abp140p-GFP dynamics in yeast bearing a deletion in *MDM20*. Mdm20p was originally identified in a screen for mutations affecting mitochondrial inheritance ([@bib27]). Deletion of *MDM20* results in reduced actin cable length, but has no effect on alignment of actin cables along the mother-bud axis. Recent evidence indicates that Mdm20p is associated with Nat3p, a protein that catalyzes acetylation of Tpm1p ([@bib65]). We find that deletion of *MDM20* has no significant effect on the rate of retrograde actin cable flow ([Fig. 6](#fig6){ref-type="fig"}).

Isoform-specific role for Tpm2p in type II myosin--driven actin filament sliding in vitro
-----------------------------------------------------------------------------------------

We found that the type II myosin Myo1p stimulates the rate of actin cable retrograde flow, whereas the tropomyosin Tpm2p has a negative effect on this process. Because both proteins bind to the lateral surface of F-actin, it is possible that Tpm2p regulates actin cable dynamics by competing with type II myosin for binding to F-actin within actin cables. One approach to test this model is to study actin cable dynamics in a cell bearing a deletion of *MYO1* and *TPM2*. In the strains used for these studies, deletion of *MYO1* and *TPM2* produced synthetic lethality. Because Myo1p and Tpm2p have functions that are not related to their function in retrograde actin cable flow, and all strains used to generate the double mutant also carried a GFP tag on the *ABP140* gene, the basis for the synthetic lethality is not readily apparent. Therefore, we could not evaluate retrograde actin cable flow in a *myo1Δ* *tpm2Δ* double mutant.

As an alternative approach to test this model, we performed in vitro assays to determine whether the tropomyosins exhibit isoform-specific effects on type II myosin motor--driven microfilament sliding and on the binding of type II myosin to F-actin. We found that type II myosin of budding yeast supports microfilament sliding in vitro. The assay used was a modification of a previously described assay ([@bib54]). GFP-tagged type II myosin from whole-cell extracts was immobilized in a microscope flow cell using anti-GFP antibody. The flow cell was treated with unlabeled F-actin and ATP to saturate ATP-insensitive, rigor-binding sites on immobilized type II myosin. Rhodamine-phalloidin--stained and stabilized yeast F-actin was then added in ATP- free buffer, and ATP was then added after washes to remove unbound material. Type II myosin--driven microfilament sliding was then monitored through time-lapse imaging.

Microfilament sliding driven by the yeast type II myosin was similar to that observed for other actin-based motors ([Fig. 7 A](#fig7){ref-type="fig"}). Microfilament sliding was unidirectional, continuous, and parallel to the long axis of the filament. The rate of movement of microfilament sliding was 0.63 ± 0.10 μm/s. This rate is similar to the rate of 0.5 μm/s observed for microfilament sliding by type II myosin isolated from the fission yeast *Schizosaccharomyces pombe* ([@bib44]). To our knowledge, this is the first direct evidence that the type II myosin of budding yeast has motor activity on actin.

![**Tpm2p exerts isoform-specific effects on F-actin binding to myosin II and myosin II--mediated actin filament gliding.** Myo1p-GFP was adsorbed from whole-cell lysate of yeast expressing GFP-tagged type II myosin protein (THY158) to a coverslip in an imaging flow cell using anti-GFP antibody. Chambers were preincubated with unlabeled actin and washed with ATP to block irreversible actin binding. Rhodamine-phalloidin--labeled actin filaments were added to the chamber. Upon addition of ATP, time-lapse imaging in a single focal plane was performed. (A) Still-frame images from a time-lapse series of rhodamine-phalloidin--labeled actin filaments gliding on a Myo1p-coated coverslip in the presence of ATP. Bar, 2 μm. (B) Tropomyosins purified from yeast bind to 10 μM actin with single micromolar affinity. Binding was determined by cosedimentation with F-actin in high-speed ultracentrifugation, followed by PAGE and quantitative densitometry of Coomassie-stained bands. Points shown are the means of three separate experiments. (C) Isoform-specific effects of Tpm2p on microfilament gliding on immobilized Myo1p. Average rates of actin filament gliding on a Myo1p-coated coverslip of actin alone or actin prebound to saturating levels (20 μM) of Tpm1p or Tpm2p. Asterisk indicates a significant reduction in the rate of actin filament gliding in the presence of saturating Tpm2p (P \< 0.05). Error bars represent the SD. *n* \> 40 for each condition. (D) Isoform-specific effects of Tpm2p on binding of F-actin to Myo1p. 20 μM phalloidin-stabilized yeast F-actin was pretreated with 10 μM purified Tpm1p or Tpm2p at 4°C for 15 min. 30 μl of the pretreated actin was mixed with magnetic beads containing immobilized Myo1p-GFP. Nucleotide (ATP or ADP) was added to a final concentration of 160 μM and the reaction mixture was incubated at 4°C for 75 s. Magnetic beads were separated from the reaction mixture and solubilized in SDS sample buffer. A 20-μl aliquot of the supernatant was also solubilized in SDS sample buffer. Solubilized material was analysis by SDS-PAGE and Western blots. Purification of actin, Tpm1p, and Tpm2p was performed as described in Materials and methods. Immobilization of Myo1p-GFP on magnetic beads, separation of magnetic beads from the binding reaction mixture, and solubilization and analysis of magnetic beads and supernatant after binding were all performed as for [Fig. 4](#fig4){ref-type="fig"}. Asterisks mark IgG heavy and light chains. The image shown is a single blot that was exposed at two different times to produce similar density for all Myo1p-GFP bands. Lanes 1--4 (left) and lanes 5--8 (right) were from different exposures.](jcb1750957f07){#fig7}

To determine whether tropomyosins exert isoform-specific effects on this process, we used established protocols to purify Tpm1p from yeast carrying a deletion in *TPM2*, and Tpm2p from yeast carrying a deletion in *TPM1*. Pull-down assays, which measured binding of the yeast tropomyosins to yeast actin, revealed that purified Tpm1p and Tpm2p retained biological activity ([Fig. 7 B](#fig7){ref-type="fig"}). The affinity of purified Tpm1p and Tpm2p for yeast actin is similar to that reported previously for rabbit skeletal muscle actin ([@bib47]).

Finally, we tested the effects of Tpm1p and Tpm2p on type II myosin--driven microfilament sliding and on binding of F-actin to type II myosin. To do so, we compared the rates of type II myosin--driven sliding of F-actin that was either untreated or pretreated with saturating amounts of Tpm1p or Tpm2p ([Fig. 7 C](#fig7){ref-type="fig"}). We found that the rate of microfilament gliding of F-actin containing bound Tpm1p (0.64 ± 0.10 μm/s) was similar to that observed for untreated F-actin without tropomyosin (0.63 ± 0.10 μm/s). In contrast, the rate of sliding of actin filaments containing bound Tpm2p (0.41 ± 0.12 μm/s) was significantly lower than that observed for either untreated or Tpm1p-treated F-actin. Interestingly, Tpm2p exhibits isoform-specific effects on type II myosin--driven microfilament sliding in vitro that is equal and opposite to the observed effect of deletion of *TPM2* on type II myosin--mediated retrograde actin cable flow in vivo. This finding is consistent with the interpretation that Tpm2p exerts an isoform-specific effect on inhibition of binding of F-actin to yeast type II myosin. To test this hypothesis directly, phalloidin-stabilized yeast F-actin was pretreated with equal amounts of purified Tpm1p or Tpm2p, and tested for binding to immobilized type II myosin ([Fig. 7 D](#fig7){ref-type="fig"}). At the concentrations tested, we found that Tpm2p, but not Tpm1p, inhibited the binding of actin filaments to type II myosin of budding yeast.

Discussion
==========

Retrograde actin flow occurs in cortical actin networks in both motile and nonmotile cells, as well as in actin bundles in apical protrusions including microvilli, filopodia, and stereocilia. Several studies support a role for type II myosin and a tropomyosin in this process. First, both proteins localize to the lamella, an actin network that is proximal to the lamellipodium and exhibits retrograde flow in migrating cells ([@bib50]). Second, retrograde flow of actin lamella and of actin bundles in neuronal filopodia is perturbed by 2,3-butanedione monoxime and blebbistatin, agents that inhibit type II myosin ATPase activity ([@bib39]; [@bib72]; [@bib59]; [@bib50]; [@bib23]; [@bib48]). Third, microinjection of the skeletal muscle tropomyosin, but not endogenous tropomyosin, into PtK1 cells produces an altered rate of retrograde actin flow ([@bib23]).

Although type II myosins and specific tropomyosin isoforms have been implicated in retrograde actin flow in animal cells, there was no evidence for a role of these proteins in actin cable dynamics in budding yeast. Moreover, the precise function of tropomyosin in retrograde actin flow in animal cells has been unclear. We provide evidence that type II myosin and a specific tropomyosin contribute to the retrograde flow of actin cables in budding yeast. Our findings are consistent with a role for type II myosin in providing a pulling force on actin cables as they undergo retrograde flow. Our findings also indicate that type II myosin and Tpm2p may have antagonistic effects during retrograde actin cable flow. Tpm2p may exert its isoform-specific negative regulatory effect by inhibiting the binding of type II myosin with F-actin within actin cables. These findings indicate that retrograde actin flow is conserved from yeast to animal cells, and extend our understanding of the mechanism of action of type II myosin and tropomyosin in this process.

A new role for type II myosin in budding yeast
----------------------------------------------

Although type II myosin has been implicated in cytokinesis in many cell types, the precise role of this protein in budding yeast remains enigmatic. Type II myosin is present at the bud neck during contractile ring closure ([@bib5]; [@bib41]). However, localization studies have revealed that this type II myosin protein behaves differently compared with other actomyosin ring components. Specifically, actin and other resident contractile ring components localize to the bud neck at the G~2~--M transition in the cell cycle ([@bib5]; [@bib71]; [@bib68]). In contrast, Myo1p localizes to the bud neck earlier in the cell cycle, during G~1~ phase, immediately after commitment to a round of cell division. In addition, recent data suggests that the motor domain of type II myosin may not be required for cytokinesis in budding yeast. Specifically, [@bib45] have showed that budding yeast expressing the type II myosin tail in lieu of the wild-type protein exhibit relatively normal cytokinesis, with relatively little change in the rate of actin ring constriction and disassembly at the bud neck.

We find that deletion or mislocalization of type II myosin results in a reduction in the rate of retrograde actin cable flow. These observations indicate that localization of the protein at the bud neck is critical for its function in retrograde actin cable flow. Moreover, because retrograde actin cable flow occurs from the time of commitment to cell division until the end of cytokinesis in budding yeast, these observations explain why type II myosin localizes earlier to the bud neck during G~1~--M stages in the cell cycle, well before the actomyosin ring is assembled.

We also find that deletion or mutation of the type II myosin motor domain produces a decrease in the rate of retrograde actin cable flow that is similar to that observed upon deletion or mislocalization of full-length type II myosin. These observations indicate that type II myosin may exert a pulling force on actin cables as they move through the bud neck, a known "bottleneck" for intracellular transport in budding yeast. Additionally, because actin cables can assemble at the bud neck, type II myosin may pull newly assembled segments of actin cable away from the assembly site, providing greater access to the end of actin cables for the assembly machinery to continue cable assembly and elongation.

Tropomyosin function in budding yeast
-------------------------------------

We find that deletion of *TPM2*, but not *TPM1*, increases the rate of retrograde actin cable flow. These observations reveal a first isoform-specific function for Tpm2p as a negative regulator of retrograde actin cable flow in budding yeast. Moreover, we found that Tpm2p, but not Tpm1p, inhibits the binding of type II myosin to F-actin and microfilament gliding in vitro. Therefore, our evidence supports a model whereby Tpm2p exerts isoform-specific inhibition of retrograde actin cable flow by inhibiting the binding of type II myosin to F-actin present in dynamic actin cables.

Our studies also extend our understanding of the regulation of tropomyosin acetylation in budding yeast. Tropomyosins in yeast and other eukaryotes are modified by N-terminal acetylation. This cotranslational modification is essential for binding of tropomyosin to F-actin ([@bib47]). The mechanism for acetylation of Tpm2p is not known. However, recent studies indicate that Mdm20p functions with Nat3p to acetylate Tpm1p and regulate its actin-binding activity ([@bib65]). Because deletion of *TPM2* increases the rate of retrograde actin cable flow, whereas deletion of either *MDM20* or *TPM1* has no effect on that process, we conclude that Mdm20p may not contribute to acetylation of Tpm2p.

Finally, these studies also extend our understanding of Tpm1p function in budding yeast. As described in the Introduction, one primary function of Tpm1p is to control actin cable stability and function. We find that Tpm1p binds to F-actin, but does not inhibit the binding of type II myosin to F-actin. Thus, the isoform-specific biochemical activity of Tpm1p is optimal for its function in budding yeast; it allows Tpm1p to stabilize actin cables without interfering with the ability of actin cables to serve as tracks for myosin-driven cargo transport during bud formation and growth.

The functions of retrograde flow
--------------------------------

Because actin cables undergo retrograde flow, the track for anterograde movement is itself moving in the direction opposite that of transport. As a result, cargos that use actin cables as tracks are "swimming upstream" and must overcome the opposing force of retrograde actin cable flow. The rate of secretory vesicle movement driven by the essential type V myosin Myo2p (∼3 μm/s) is an order of magnitude higher than the rate of retrograde actin cable flow ([@bib61]). In this case, retrograde actin cable flow may not have any significant effect on anterograde transport. In contrast, the rates of Arp2/3 complex--driven anterograde mitochondrial movement (0.3 μm/s) and of type V myosin (Myo4p)--driven mRNA movement (0.03 μm/s) are significantly lower ([@bib4]; [@bib16]). In these cases, retrograde actin cable flow may have a significant effect on anterograde transport. In the case of mitochondria, we have proposed that actin cable dynamics favor bud-directed transport, and therefore would also favor inheritance of organelles that can harness the most robust anterograde force--generating machinery, i.e., inheritance of the "fittest" mitochondria ([@bib8]). Thus, retrograde actin cable flow can affect the rate and efficacy of anterograde transport.

Work from this laboratory and others revealed a second function for retrograde actin flow---driving retrograde movement. Retrograde flow of actin networks in the leading edge of motile cells can drive movement of surface receptors and tubulin ([@bib9]; [@bib72]; [@bib59]). Retrograde actin flow has also been shown to drive movement of the nucleus, which results in reorientation and polarization of the microtubule-organizing center in migrating cells ([@bib18]). In budding yeast, mitochondria and actin patches bind to actin cables undergoing retrograde flow and use actin cables as "conveyor belts" for retrograde movement ([@bib16]; [@bib29]). Indeed, because genes encoding pointed-end--directed myosins have not been identified in the yeast genome, retrograde actin flow may be the primary force for actin-dependent retrograde movement in this cell type. Thus, retrograde actin flow can drive retrograde movement in yeast and other eukaryotic cell types. Equally important, the organization and dynamics of actin cables in budding yeast allow for bidirectional movement using a single polarized cytoskeletal structure.

Finally, our finding that Tpm2p can regulate the rate of type II myosin--driven retrograde actin cable flow raises the question of why regulating retrograde flow rates would benefit the cell. A twofold increase in the rate of actin cable retrograde flow would have a significant impact on the rate of anterograde transport of mitochondria and mRNA. Thus, regulation of retrograde actin cable flow can affect mitochondrial inheritance and mRNA localization. Regulation of retrograde flow rates in budding yeast may also affect retrograde movement of mitochondria during inheritance, as well as retrograde movement of endosomes and their subsequent fusion with the sorting compartment. Indeed, our preliminary evidence indicates that the rate of retrograde endosome movement is reduced in yeast bearing mutations that inhibit retrograde actin cable flow. Studies designed to further evaluate the physiological role of altering the rate of actin cable retrograde flow are ongoing.

Materials and methods
=====================

Yeast strains and plasmids
--------------------------

Yeast strains used in this study are listed in [Table II](#tbl2){ref-type="table"}. With the exception of the *myo3Δ* *myo5Δ* strain, which is in the W303 genetic background, all strains used are S288C. Yeast cell growth and manipulations were performed according to established protocols ([@bib62]). To visualize actin cables in living cells, the C terminus of Abp140p was tagged with GFP (S65T) using PCR-based insertion of the GFP gene ([@bib43]) into the chromosomal copy of *ABP140,* as previously described ([@bib75]). The cassette used to insert GFP into the *ABP140* gene of wild-type and myosin mutant cells was amplified from pFA6a:GFP (S65T):*HIS3* with the following primers: forward 5′- AAATATTGATAGTAACAATGCACAGAGTAAAATTTTCAGTCGGATCCCCGGGTTATTAA-3′ and reverse 5′-AAAGGATATAAAGTCTTCCAAATTTTTAAAAAAAAGTTCGGAATTCGAGCTCGTTAAAC-3′. Amplified DNA was transformed into the strains of interest, and cells that had integrated the GFP cassette into the *ABP140* gene were selected by their ability to grow on synthetic media lacking histidine.

###### 

**Yeast strains used in this study**

  -------------------------------------------------------------------------------------------------------------------------
  Strain      Genotype                                                                                    Source
  ----------- ------------------------------------------------------------------------------------------- -----------------
  YCY006      MATα *can1-100 ade2-1 his3-11 leu2-3,112 ura3-1 trp1-1 ABP140*∷*GFP*∷*KanMX6*               [@bib75]

  YCY009      MATα *can1-100 ade2-1 his3-11 leu2-3,112 ura3-1 trp1-1 myo3Δ*∷*HIS3 myo5Δ*∷*TRP1*\          this study
                   *ABP140*∷*GFP*∷*KanMX6*                                                                

  YCY010      MATα *leu2-3,112 his3-200 ura3-52 myo2-66*∷*HIS3 myo4Δ*∷*URA3 ABP140∷GFP∷KanMX6*            this study

  YCY027      MATα *his3Δ* *leu2Δ* *met15Δ* *ura3Δ* *ABP140∷GFP∷KanMX6*                                   [@bib29]

  THY114-2d   MATα *his3Δ* *leu2Δ* *met15Δ* *lys2Δ* *ura3Δ* *mdm20Δ*∷*KanMX6 ABP140∷GFP∷KanMX6*           this study

  THY118      MATα *his3Δ* *leu2Δ* *met15Δ* *ura3Δ* *tpm1Δ*∷*KanMX6 ABP140∷GFP∷HIS3*                      this study

  THY119      MATα *his3Δ* *leu2Δ* *met15Δ* *ura3Δ* *tpm2Δ∷KanMX6 ABP140∷GFP∷HIS3*                        this study

  THY120      MATα *leu2-3,112 ura3-52 ade1-101 myo1Δ*∷*URA3 ABP140∷GFP∷KanMX6*                           this study

  THY158      MATα *his3Δ* *leu2Δ* *met15Δ* *ura3Δ* *MYO1∷GFP∷HIS3*                                       this study

  THY159      MATα *his3Δ* *leu2Δ* *met15Δ* *ura3Δ* *MYO1∷GFP∷HIS3* pTH12 (*MYO1-tail*)*∷URA3*            this study

  THY160      MATα *his3Δ* *leu2Δ* *met15Δ* *ura3Δ* *ABP140∷GFP∷KanMX6* pTH12 (*pGal-MYO1-tail*)*∷URA3*   this study

  THY192      MATα *his3Δ* *leu2Δ* *met15Δ* *ura3Δ* *ABP140∷GFP∷kanMX* pTH15 (*myo1-66∷GFP)∷URA3*         this study

  THY193      MATα *his3Δ* *leu2Δ* *met15Δ* *ura3Δ* *ABP140∷GFP∷kanMX* pTH15 (*myo1-66∷GFP)∷URA3*\        this study
                   *myo1Δ∷HIS3*                                                                           

  THY194      MATα *his3Δ* *leu2Δ* *met15Δ* *ura3Δ* p846 (*MYO1-GFP*)*∷URA3*                              this study

  THY195      MATα *his3Δ* *leu2Δ* *met15Δ* *ura3Δ* pTH14 (*myo1-66*)*∷URA3*                              this study

  THY196      MATα *his3Δ* *leu2Δ* *met15Δ* *ura3Δ* *tpm2Δ∷kanMX* pEH002 (*GAL-TPM1*)*∷URA3*              this study

  THY197      MATα *his3Δ* *leu2Δ* *met15Δ* *ura3Δ* *tpm1Δ∷kanMX* pEH006 (*GAL-TPM2*)*∷URA3*              this study

  VSY21       MATα *leu2-3,112 his3-200 ura3-52 myo2-66*∷*HIS3 myo4Δ*∷*URA3*                              [@bib63]

  HA31-9c     MATα *can1-100 ade2-1 his3-11 leu2-3,112 ura3-1 trp1-1 myo3Δ*∷*HIS3 myo5Δ*∷*TRP1*           [@bib20]

  BN4         MATα *leu2-3,112 ura3-52 ade1-101 myo1Δ*∷*URA3*                                             [@bib49]

  BY4741      MATα *his3Δ* *leu2Δ* *met15Δ* *ura3Δ*                                                       Open Biosystems

  RG7224      MATα *his3Δ* *leu2Δ* *met15Δ* *ura3Δ* *tpm1Δ*∷*KanMX6*                                      Open Biosystems

  RG2297      MATα *his3Δ* *leu2Δ* *met15Δ* *ura3Δ* *tpm2Δ*∷*KanMX6*                                      Open Biosystems

  RG11767     MATα *his3Δ* *leu2Δ* *lys2Δ* *ura3Δ* *mdm20Δ*∷*KanMX6*                                      Open Biosystems

  TLY002      MATα *his3Δ* *leu2Δ* *met15Δ* *ura3Δ* *ABP140∷GFP∷kanMX* pTL02 (*MYO1∷GFP)∷LEU2*            this study

  TLY003      MATα *his3Δ* *leu2Δ* *met15Δ* *ura3Δ* *ABP140∷GFP∷kanMX* pTL03 (*MYO1-Tail∷GFP)∷LEU2*       this study
  -------------------------------------------------------------------------------------------------------------------------

The strain containing a deletion in the *MDM20* gene and a GFP tag on Abp140p (THY114-2d) was constructed by mating a haploid *mdm20Δ* cell (RG11767) with a wild-type cell expressing Abp140p-GFP (YCY027). The resulting diploids were sporulated in medium containing 1% KOAc + 0.025% glucose, and haploids produced from the diploids were selected using a visual screen for GFP-labeled actin cables and PCR to verify deletion of the gene of interest.

Plasmid pTH12 is a two-micrometer plasmid that encodes the 868 C-terminal amino acids of Myo1p under the control of the *GAL1-10* promoter (similar to that described by [@bib69]). For the construction, DNA encoding the tail region of *MYO1* was amplified from wild-type yeast genomic DNA using the following forward and reverse primers: 5′-TCA[GGATCC]{.ul}TGACATAAAATTGGTCACTTTAGA-3′ and 5′-AGTTAA[A]{.ul} [AGCTT]{.ul}TTAACTGAAAATTTTACTCTGTGCATT-3′, respectively. The forward primer contains a BamHI restriction site and the reverse primer contains a HindIII restriction site. Restriction sites are underlined. The product was purified and ligated into the BamHI and HindIII sites of the plasmid pGAL68. The resulting vector contains an in-frame ATG from codon 1060 of *MYO1* downstream of the *GAL1* promoter. Induction of Myo1p tail overexpression was performed by shifting cells from synthetic media supplemented with raffinose into synthetic media containing both raffinose and galactose.

Plasmid pTH14 is a CEN-based plasmid that contains the *MYO1* promoter within 555 bases of the upstream untranslated region of the gene followed by a GFP (S65T)-tagged *MYO1* gene that carries an E528K mutation (*myo1-66*). To construct this plasmid, site-directed mutagenesis was performed on the plasmid p846 using the QuikChange Site-Directed Mutagenesis kit (Stratagene), which is a PCR-based method for mutagenesis. Primers were designed to mutate glutamate 528 to a lysine by a single nucleotide substitution (GAA→AAA). After PCR amplification, the mutated fragment was cleaved using AgeI and BclI and reinserted into p846. This new plasmid was sequenced to confirm the presence of the mutation. The plasma used to construct pTH14, which contains wild-type MYO1, was provided by E. Bi (University of Pennsylvania, Philadelphia, PA).

Plasmids pTL2 and pTL3 are centromere-based plasmids that contain full-length *MYO1* and the *MYO1* tail (aa 842--1,928) under control of the *MYO1* promoter. These plasmids were produced from pGFP-MYO1 and pGFP-MYO1-*Tail*, which were generously provided by M. Lord (University of Vermont, Burlington, VT) and T. Pollard (Yale University, New Haven, CT; [@bib45]). To allow for transformation into strains of interest, the *TRP1* marker on pGFP-MYO1 and pGFP-MYO1-*Tail* was replaced with *LEU2*. To do so, the *TRP1* marker was excised from pGFP-MYO1 and pGFP-MYO1-*Tail* by digestion with PvuI. The *LEU2* marker, which was amplified from pRS415, was then inserted into the plasmid at the PvuI site.

Microscopy and image analysis
-----------------------------

For time-lapse fluorescence imaging of Abp140p-GFP, cells were grown in synthetic complete or lactate medium ([@bib75]) until early log phase at 25°C. 3 μl of cell suspension was applied to a microscope slide and covered with a coverslip. Microscopy was performed using a microscope (E600; Nikon) equipped with a Plan Apo ×100/1.4 NA objective and a cooled charge-coupled device camera (Orca-ER; Hamamatsu). Illumination with a 100 W mercury arc lamp was controlled with a shutter (Uniblitz D122; Vincent Associates). The temperature of the objective lens was controlled using an objective heater (Bioptechs). Images were collected and analyzed using Openlab 3.0.8 software (Improvision) and ImageJ 1.28 (National Institutes of Health), respectively. The exposure time and time interval between successive image acquisitions were 400 and ∼500 ms, respectively. The total imaging time for the time-lapse imaging was 20 s. For determination of the velocity of elongating actin cables, the change in position of fluorescent fiduciary marks on elongating cables was measured as a function of time, as previously described ([@bib75]).

Time-lapse imaging of fluorescently labeled actin filaments in actin- gliding assays was performed as described in the previous paragraph. The exposure time and time interval between successive image acquisitions were 400 and 500 ms, respectively. The total imaging time for the time-lapse imaging was 50 s. For determination of the velocity of microfilament gliding, the change in position of the tips of gliding actin filaments was measured as a function of time, as previously described ([@bib75]).

For analysis of the localization of GFP-tagged wild-type and *myo1-66* mutant proteins, 25 z sections were obtained at 0.2-μm intervals through the entire cell. Z sectioning for 3D imaging was performed using a piezoelectric focus motor mounted on the objective lens of the microscope (Polytech PI). Out-of-focus light was removed by digital deconvolution, and each series of deconvolved images was projected and rendered with Volocity software (Improvision, Inc.).

Protein purification
--------------------

Yeast actin was isolated from *S. cerevisiae* as previously described ([@bib6]). In brief, actin was purified from cell lysate by DNase affinity chromatography, followed by ion-exchange chromatography using DE52. Peak fractions were pooled and subjected to multiple rounds of polymerization/depolymerization to ensure polymerization-competent actin. Yeast tropomyosins (Tpm1p and Tpm2p) were purified as previously described ([@bib47]). Tpm1p was purified from a strain that carries a deletion in the *TPM2* gene and is transformed with a plasmid bearing *TPM1* under control of the galactose-inducible *GAL1* promoter (THY196). Tpm2p was purified from a strain that carries a deletion in the *TPM1* gene and is transformed with a plasmid bearing *TPM2* under control of the galactose-inducible *GAL1* promoter (THY197). Tropomyosin constructs were provided by A. Bretscher and D. Pruyne (Cornell University, Ithaca, NY). Protein concentrations were determined using the bicinchoninic acid protein assay reagent (Pierce Chemical Co.) according to the manufacturer\'s protocol.

Preparation of yeast cell lysate
--------------------------------

For purification of actin and the GFP-tagged wild-type and mutant Myo1p proteins from yeast, cells were grown to mid-log phase, concentrated by centrifugation (1,500 *g* for 10 min), and suspended in cell lysate buffer (25 mM imidazole-HCl, pH 7.4, 25 mM KCl, 4 mM MgCl~2~, 200 μM ATP, 2 mM DTT, 1 mM EGTA, 1 mM PMSF, and a previously described protease inhibitor cocktail \[[@bib36]\]). The cell suspension was then added drop-wise into liquid nitrogen. The resulting frozen pellets were ground in a liquid nitrogen--cooled coffee grinder for 5--10 s, and the ground powder was stored at --80°C. The ground powder was thawed at 4°C and clarified by centrifugation at 1,500 *g* for 4 min at 4°C. The pellet was discarded and the supernatant was used as in whole-cell lysate for microfilament gliding and myosin--actin--binding assays.

For quantitation of the steady-state level of Myo1p and myo1-66p, cells were grown to mid-log phase (OD~600~ = 0.7) in 10 ml of synthetic complete--ura liquid medium. Cells were concentrated by centrifugation, washed with distilled water, and resuspended in 300 μl lysis buffer (50 mM imidazole, pH 7.4, 1% Triton X-100, 2 mM PMSF, and protein inhibitor cocktails 1 and 2). 1 ml of 0.5-mm glass beads (Biospec Products, Inc.) were washed in lysis buffer and added to the cell suspension. The mixture was vortexed vigorously for 6 min at 4°C. Thereafter, 200 μl of the lysate was removed and mixed with 66.6 μl of 4× SDS sample buffer. The mixture was incubated at 100°C for 3--4 min. Proteins in the solubilized lysate were analyzed by SDS-PAGE, followed by Western blots.

Tropomyosin--actin--binding assays
----------------------------------

Purified yeast tropomyosins at the indicated concentrations were added to 0.4 mg/ml F-actin in tropomyosin-binding buffer (150 mM KCl, 5 mM MgCl~2~, 10 mM Tris-HCl, pH 7.5, 1 mM EGTA, and 1 mM DTT). Samples were incubated for 20 min at 4°C. Samples were then subjected to ultracentrifugation for 20 min at 100,000 *g* at 4°C in a fixed angle rotor (TA 100.3) using a ultracentrifuge (TL-100; both Beckman Coulter). Supernatant was removed, and the pellet was resuspended in an equal volume of SDS sample buffer. Equal volumes were loaded in wells of a polyacrylamide gel and subjected to electrophoresis, followed by Coomassie blue staining. Quantitative densitometry was performed to assess the cosedimentation of tropomyosin with actin (bound vs. unbound fractions).

Microfilament gliding assays
----------------------------

### Construction of nitrocellulose-coated flow chambers.

Ethanol- washed coverslips were coated with 0.5% nitrocellulose and allowed to air-dry. The coverslip was then applied onto a microscope slide with the coated side facing down, using double-stick tape as adherent spacers. The resultant flow chamber volume was ∼30 μl.

### Immobilization of GFP-tagged type II myosin in the flow chamber.

0.5 mg/ml protein A in TBS was added to the flow chamber and allowed to incubate for 30 min at RT. Unbound protein A was removed by three washes with TBS. 50 μg/ml anti-GFP antibody (Roche) was added to the flow chamber and allowed to incubate for 30 min at RT. Unbound antibody was removed by three washes with PBS. To prevent nonspecific binding, 5 mg/ml BSA in TBS was added, and after a 30-min incubation at RT, unbound material was removed by two washes with TBS and two washes with cell lysate buffer. Finally, cell lysate from THY158 (wild-type cells expressing C-terminally GFP-tagged Myo1p) was added to the flow chamber and incubated for 2--4 h at 4°C. Unbound material was removed by two washes with motility buffer (25 mM imidazole HCl, pH 7.4, 25 mM KCl, 4 mM MgCl~2~, 1 mM EGTA, 600 mM sorbitol, 9.35 U/ml glucose oxidase, 3.6 μg/ml catalase, 3 mg/ml glucose, 1 mM PMSF, 10 mM DTT, and protease inhibitor cocktail as described in the previous sections) supplemented with 4 mg/ml BSA, followed by two washes in BSA-free motility buffer.

### Pretreatment with unlabeled F-actin.

To block all rigor-binding sites of immobilized type II myosin, unlabeled phalloidin-stabilized yeast actin filaments (25 μg/ml in motility buffer) were added to the flow chamber and allowed to incubate for 2 min at 4°C. Unbound material was then removed by two washes with motility buffer supplemented with 10 μM ATP and an ATP-regenerating system (10 mM creatine phosphate and 100 μg/ml creatine phosphokinase). Unbound material was removed by three washes with motility buffer.

### Visualization of microfilament gliding.

Yeast F-actin that was fluorescently labeled and stabilized with rhodamine phalloidin was suspended in ATP-free motility buffer to a final concentration of 10 μg/ml. This solution was added to the flow chamber containing immobilized type II myosin. After incubation at RT for 2 min, unbound material was removed by two washes with motility buffer. The microscope slide flow chamber was placed on the stage of an epifluorescence microscope (see above). Motility buffer containing ATP and an ATP-regenerating system was added and microfilament gliding was monitored by time-lapse fluorescence imaging as described in Microscopy and image analysis.

Myosin--actin--binding assays
-----------------------------

Goat anti--mouse IgG magnetic beads (New England Biolabs; 10 μl per reaction) were washed three times with sterile-filtered TBS, pH 8.0, and incubated with 5 μg of mouse anti-GFP IgGs (Roche) for 1 h at 4°C. Beads were washed two times in sterile-filtered TBS and two times in lysate buffer, and then incubated with 100 μl of either 1 mg/ml BSA, lysate from cells expressing GFP-tagged Myo1p, or lysate from cells expressing GFP-tagged *myo1-66*p for 2 h at 4°C. Beads were washed twice in lysate buffer and twice with motility buffer to remove unbound material. Phalloidin-stabilized yeast F-actin was added at the concentrations indicated in the presence of 1 mM ATP or ADP, pH 7.4. After incubation at 4°C for 90 s, beads were separated from the supernatant. Bound material (beads) and unbound material were solubilized in SDS sample buffer and subjected to PAGE and Western blot analysis using antibodies that recognized GFP and actin. Quantitative densitometry was performed to assess the fraction of actin that was bound to myosin or released to the supernatant.

Online supplemental material
----------------------------

Video 1 shows retrograde actin cable flow in wild-type cells. Video 2 shows retrograde actin cable flow in myo1Δ cells. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200609155/DC1>.
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